BATM Advanced Communications Ltd. (LON:BVC)
14.45
-0.55 (-3.67%)
Feb 12, 2026, 5:07 PM GMT
LON:BVC Market Cap
LON:BVC has a market cap or net worth of 49.14 million as of February 12, 2026. Its market cap has decreased by -40.36% in one year.
Market Cap
49.14M
Enterprise Value
35.09M
Revenue
86.72M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.45
Market Cap Chart
Since March 30, 1998, LON:BVC's market cap has increased from 47.21M to 49.14M, an increase of 4.10%. That is a compound annual growth rate of 0.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 51.01M | -27.59% |
| Dec 31, 2025 | 70.45M | -12.53% |
| Dec 31, 2024 | 80.54M | -8.79% |
| Dec 29, 2023 | 88.30M | -26.09% |
| Dec 30, 2022 | 119.47M | -67.74% |
| Dec 31, 2021 | 370.41M | -9.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 215.40B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| Creo Medical Group | 70.43M |
| Hemogenyx Pharmaceuticals | 55.28M |
| SkinBioTherapeutics | 51.13M |
| Kooth | 48.10M |